Novel dissolution methods for drug release testing of Long-Acting injectables
Authors:
- 28 August 2024
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 664, 124634
Abstract
No abstract availableKeywords
Funding Information
- University of Connecticut
- Pfizer Global Pharmaceuticals
This publication has 31 references indexed in Scilit:
- Long-acting parenteral drug delivery systems for the treatment of chronic diseasesAdvanced Drug Delivery Reviews, 2023
- Drug release from in situ forming implants and advances in release testingAdvanced Drug Delivery Reviews, 2021
- Pharmacokinetic Profile of a 2-Month Dose Regimen of Aripiprazole Lauroxil: A Phase I Study and a Population Pharmacokinetic ModelCNS Drugs, 2017
- A New Level A Type IVIVC for the Rational Design of Clinical Trials Toward Regulatory Approval of Generic Polymeric Long-Acting InjectablesClinical Pharmacokinetics, 2016
- A reproducible accelerated in vitro release testing method for PLGA microspheresInternational Journal of Pharmaceutics, 2016
- Mathematical models of drug release2015
- Development and comparison of intramuscularly long-acting paliperidone palmitate nanosuspensions with different particle sizeInternational Journal of Pharmaceutics, 2014
- Formulation parameters of crystalline nanosuspensions on spray drying processing: A DoE approachInternational Journal of Pharmaceutics, 2014
- USP apparatus 4 method for in vitro release testing of protein loaded microspheresInternational Journal of Pharmaceutics, 2011
- Current perspectives in dissolution testing of conventional and novel dosage formsInternational Journal of Pharmaceutics, 2007